Citi Upgrades Biogen (BIIB) to Buy
Tweet Send to a FriendGet Alerts BIIB Hot Sheet
Price: $210.80 +1.47%
Rating Summary:
16 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
16 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade BIIB Now!
Citi upgraded Biogen (NASDAQ: BIIB) from Neutral to Buy with a price target of $187.00 (from $160.00).
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $160.30 yesterday, with a 52 week range of $114.53-$167.35.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $160.30 yesterday, with a 52 week range of $114.53-$167.35.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Goldman Sachs Upgrades Enbridge (ENB) to Conviction Buy
- Canaccord Genuity Maintains Bullish Stance on 3D Systems (DDD), Raises Target After Analyst Day
- JPMorgan Upgrades People's United Financial (PBCT) to Overweight
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
Citi
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
